Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.1K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

5.7K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Workshop on Noninvasive Glucose Monitoring 2025.

Journal of diabetes science and technology·2026
Same author

Systemic Therapies for the Treatment of Cutaneous Malignancies in Solid Organ Transplant Recipients.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

It Is Time to Act: Making Diabetes Distress Screening Standard in Clinical Practice.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Metabolic medications modify prostate cancer progression through exosome reprogramming.

bioRxiv : the preprint server for biology·2025
Same author

Mohs micrographic surgery is non-inferior to wide local excision for disease specific survival in sebaceous carcinoma: analysis of the Surveillance, Epidemiology, and End Results (SEER) database (2000-2021).

Archives of dermatological research·2025
Same author

Social Capital in the Workplace for New Graduate Nurses: Maximizing Recruitment and Retention.

The Journal of nursing administration·2025

Related Experiment Video

Updated: Mar 20, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.6K

Type B insulin resistance syndrome.

Devina L Willard1, Mary Stevenson, Devin Steenkamp

  • 1aSection of Endocrinology, Diabetes, and Nutrition, Boston Medical Center and Boston University School of Medicine bDepartment of Internal Medicine, Boston Medical Center, Boston, Massachusetts, USA.

Current Opinion in Endocrinology, Diabetes, and Obesity
|June 3, 2016
PubMed
Summary

Type B insulin resistance syndrome, an autoimmune disorder, presents with extreme insulin resistance. Recent immunomodulatory therapies show promise in improving outcomes and reducing mortality associated with this rare condition.

More Related Videos

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

20.9K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

72.4K

Related Experiment Videos

Last Updated: Mar 20, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

3.6K
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
08:03

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes

Published on: June 25, 2017

20.9K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

72.4K

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Background:

  • Type B insulin resistance syndrome is a rare autoimmune disorder.
  • Characterized by autoantibodies targeting the insulin receptor.
  • Often associated with other autoimmune conditions.

Purpose of the Study:

  • Review the epidemiology of Type B insulin resistance syndrome.
  • Describe the pathophysiology and clinical features.
  • Highlight recent advances in management.

Main Methods:

  • Literature review of Type B insulin resistance syndrome.
  • Analysis of epidemiological data.
  • Evaluation of current and emerging treatment strategies.

Main Results:

  • Type B insulin resistance syndrome predominantly affects middle-aged Black women.
  • Cardinal features include refractory hyperglycemia and extreme insulin resistance; hypoglycemia can occur.
  • Recent combination immunomodulatory therapies improve remission durability and reduce hypoglycemia-related mortality.

Conclusions:

  • Type B insulin resistance syndrome requires a comprehensive understanding of its complex pathophysiology.
  • Advances in immunomodulatory therapy offer improved management and prognosis.
  • Further research is needed for standardized treatment protocols.